COMPLETED

Food Is Medicine for Patients With Heart Failure

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will look at the effects of providing medically tailored meals (MTMs) to people with heart disease for twelve weeks. The primary outcome of the study is the quality of the diet being consumed in week 12 of the study, as determined by the "Healthy Eating Index."

Official Title

Food Is Medicine for Patients With Heart Failure

Quick Facts

Study Start:2024-10-17
Study Completion:2025-07-28
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06540118

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Willingness to comply with all study procedures and availability for the duration of the study
  2. * Living in San Diego or the Bay Area of California
  3. * Reported congestive heart failure (CHF) diagnosis
  4. * Current diet can be improved
  5. * Willing to eat all meals provided by the study
  1. * Diagnosed with end-stage heart failure
  2. * Diagnosed with diabetes (type 1 or uncontrolled type 2)
  3. * Currently taking insulin and/or meglitinides medications
  4. * Currently taking Glucagon-Like Peptide-1 (GLP-1) Agonists medications and not stable on a maximum maintenance dose for a minimum of 1 month
  5. * Hemoglobin A1c (HbA1c) results \>8 %
  6. * Life expectancy of \<1 year
  7. * Pregnancy or lactation
  8. * Known severe allergic reactions and/or food intolerances that would interfere with the ability to eat study-provided meals, including foods that are prepared in a facility that works with the allergen
  9. * Current smoker or tobacco use within the past year
  10. * Planning to leave San Diego or the Bay Area during the course of the study
  11. * Unable to communicate reasonably well either orally or through written material in English
  12. * Those who, in the opinion of the investigators, cannot reliably complete the study protocol

Contacts and Locations

Principal Investigator

Cheryl Anderson, PhD, MPH, MS
PRINCIPAL_INVESTIGATOR
UC San Diego
Christopher Gardner, PhD
PRINCIPAL_INVESTIGATOR
Stanford University

Study Locations (Sites)

University of California San Diego
La Jolla, California, 92093
United States
Stanford University
Stanford, California, 94305
United States

Collaborators and Investigators

Sponsor: University of California, San Diego

  • Cheryl Anderson, PhD, MPH, MS, PRINCIPAL_INVESTIGATOR, UC San Diego
  • Christopher Gardner, PhD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-17
Study Completion Date2025-07-28

Study Record Updates

Study Start Date2024-10-17
Study Completion Date2025-07-28

Terms related to this study

Additional Relevant MeSH Terms

  • Heart Failure
  • Heart Failure,Congestive
  • Heart Diseases